Delay Within the 3-Hour Surviving Sepsis Campaign Guideline on Mortality for Patients With Severe Sepsis and Septic Shock.
Delay Within the 3-Hour Surviving Sepsis Campaign Guideline on Mortality for Patients With Severe Sepsis and Septic Shock.
复制标题
DOI:
10.1097/ccm.0000000000002949
复制
发表时间:
2018-04
影响因子:
8.8
通讯作者:
Simon G
中科院分区:
文献类型:
--
作者:
Pruinelli L;Westra BL;Yadav P;Hoff A;Steinbach M;Kumar V;Delaney CW;Simon G
To specify when delays of specific 3-hour bundle Surviving Sepsis Campaign (SSC) guideline recommendations applied to severe sepsis or septic shock become harmful and impact mortality. Retrospective cohort study. One health system composed of six hospitals and 45 clinics in a Midwest state from January 01, 2011 and July 31, 2015. All adult patients hospitalized with billing diagnosis of severe sepsis or septic shock. Four 3-hour SSC guideline recommendations: 1) obtain blood culture before antibiotics, 2) obtain lactate level, 3) administer broad-spectrum antibiotics, and 4) administer 30 mL/kg of crystalloid fluid for hypotension (defined as mean arterial pressure (MAP) < 65) or lactate (> 4). To determine the effect of t minutes of delay in carrying out each intervention, propensity score matching of baseline characteristics compensated for differences in health status. The Average Treatment effect in the Treated (ATT) computed as the average difference in outcomes between those treated after shorter versus longer delay. To estimate the uncertainty associated with the ATT metric and to construct 95% confidence intervals, bootstrap estimation with 1,000 replications was performed. From 5,072 patients with severe sepsis or septic shock, 1,412 (27.8%) had in-hospital mortality. The majority of patients had the four 3-hour bundle recommendations initiated within three hours. The statistically significant time in minutes after which a delay increased the risk of death for each recommendation was: lactate, 20.0 minutes; blood culture, 50.0 minutes; crystalloids, 100.0 minutes; and antibiotic therapy, 125.0 minutes. The guideline recommendations showed that shorter delays indicates better outcomes. There was no evidence that 3 hours is safe; even very short delays adversely impact outcomes. Findings demonstrated a new approach to incorporate time t when analyzing the impact on outcomes and provide new evidence for clinical practice and research.